36 results
10-Q
2018 Q1
CUE
Cue Biopharma Inc
14 May 18
Quarterly report
5:19pm
to regulatory review and approval, as well as competition from other biotechnology and pharmaceutical companies. The Company operates in an environment of rapid … to any material legal proceedings.
ITEM 1A. RISK FACTORS
We operate in a rapidly changing environment that involves a number of risks that could
8-K
EX-10.1
pm87spbo9jfcs3e3
30 Mar 22
Entry into a Material Definitive Agreement
4:10pm
8-K
EX-10.1
dvpssw 4g3x
15 Nov 22
Cue Biopharma Announces $30 Million Private Investment in Public Equity (PIPE) Financing
4:30pm
8-K
EX-1.1
4x9g p4mjwq
22 Jun 20
Entry into a Material Definitive Agreement
5:26pm
8-K
EX-1.1
pl8 ymm38iecmi
5 Jun 19
Entry into a Material Definitive Agreement
8:55am
8-K
EX-1.1
lgmmvh1of3wane6ao 94
26 Nov 19
Entry into a Material Definitive Agreement
12:00am
8-K
EX-1.1
3gmips5 v7c
27 Mar 20
Entry into a Material Definitive Agreement
4:53pm